Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma

被引:14
|
作者
Min, Wen-Pu [1 ]
Wei, Xiao-Feng [1 ]
机构
[1] Yangtze Univ, Peoples Hosp Jingzhou City 1, Dept Nucl Med, Affiliated Hosp 1, Jingzhou 434000, Hubei, Peoples R China
关键词
Papillary thyroid carcinoma; SIX1; TGF-beta/Smad2/3; Epithelial mesenchymal transition; POOR-PROGNOSIS; CANCER; EXPRESSION; GROWTH; EMT; METASTASIS; CELLS; OVEREXPRESSION; ACTIVATION; TGF-BETA-1;
D O I
10.1016/j.anl.2020.10.002
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To investigate the sineoculis homeobox homolog 1 (SIX1) affect the epithelial mesenchymal transition (EMT) in papillary thyroid carcinoma (PTC) through regulating TGF-beta/Smad2/3 signaling pathway. Methods: The SIX1 expression in cytological specimens, tissues or PTC cell lines was detected by qRT-PCR, western blotting or immunohistochemistry. A series of vitro experiments including flow cytometry, CCK-8, wound-healing and Transwell were used to evaluate the biological characteristics in a PTC cell line (NPA cells), which were divided into Blank, Negative control (NC), SIX1, SIX1-siRNA, LY-364947 (TGF-beta/Smad2/3 pathway inhibitor) and SIX1 + LY364947 groups. TGF-beta/Smad2/3 pathway and EMT related protein expression were measured by qRT-PCR and western blotting. Results: SIX1 mRNA expression was increased in cytological specimens from PTC patients as compared with the non-toxic nodular goitre (NTG) patients. Moreover, compared with adjacent normal tissues, expressions of SIX1, N-cadherin and Vimentin were higher while E-cadherin was lower in PTC tissues; and SIX1 was positively correlated with N-cadherin and Vimentin but was negatively correlated with E-cadherin. Furthermore, the SIX1 expression was associated with histopathology, extrathyroidal extension (ETE), lymph node metastasis (LNM), pT stage, TNM stage, and distant metastasis. In addition, the expressions of TGF-beta 1, p-SMAD2/3, N-cadherin and Vimentin were downregulated in NPA cells after LY-364947 treatment with upregulated Ecadherin, decreased cell proliferation and metastasis, and enhanced cell apoptosis, which was reversed by SIX1 overexpression. Conclusion: Silencing SIX1 can inhibit TGF-beta/Smad2/3 pathway, thereby suppressing EMT in PTC, which may be a novel avenue for the treatment of PTC. (C) 2020 Oto-Rhino-Laryngological Society of Japan Inc. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 50 条
  • [1] Thymoquinone inhibits epithelial-mesenchymal transition in prostate cancer cells by negatively regulating the TGF-β/Smad2/3 signaling pathway
    Kou, Bo
    Liu, Wei
    Zhao, Wei
    Duan, Peng
    Yang, Yang
    Yi, Qiuyue
    Guo, Fengwei
    Li, Jianpeng
    Zhou, Jinsong
    Kou, Qingshan
    ONCOLOGY REPORTS, 2017, 38 (06) : 3592 - 3598
  • [2] HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway
    Kou, Bo
    Liu, Wei
    Tang, Xiaoshuang
    Kou, Qingshan
    ONCOLOGY REPORTS, 2018, 39 (01) : 101 - 108
  • [3] Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway
    Fan, Qiong
    Qiu, Met-Ting
    Zhu, Zhu
    Zhou, Jin-Hua
    Chen, Limo
    Zhou, Ye
    Gu, Wei
    Wang, Li-Hua
    L, Zhu-Nan, I
    Xu, Ying
    Cheng, Wei-Wei
    Wu, Dan
    Bao, Wei
    ONCOLOGY REPORTS, 2015, 34 (04) : 1787 - 1794
  • [4] Treatment with the herbal formula Songyou Yin inhibits epithelial-mesenchymal transition in hepatocellular carcinoma through downregulation of TGF-β1 expression and inhibition of the SMAD2/3 signaling pathway
    Zheng, Susu
    Jia, Qingan
    Shen, Hujia
    Xu, Xin
    Ling, Jiajia
    Jing, Chuyu
    Zhang, Boheng
    ONCOLOGY LETTERS, 2017, 13 (04) : 2309 - 2315
  • [5] Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells
    Chen, Wei
    Zhao, Kai
    Miao, Chenkui
    Xu, Aiming
    Zhang, Jianzhong
    Zhu, Jundong
    Su, Shifeng
    Wang, Zengjun
    ONCOTARGETS AND THERAPY, 2017, 10 : 1503 - 1512
  • [6] Farrerol suppresses epithelial-mesenchymal transition in hepatocellular carcinoma via suppression of TGF-(31/Smad2/3 signaling
    Hao, Yaming
    Long, Zhixiong
    Gu, Xiufeng
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 264 : 155719
  • [7] microRNA-141 inhibits TGF-β1-induced epithelial-to-mesenchymal transition through inhibition of the TGF-β1/SMAD2 signalling pathway in endometriosis
    Wang, Sixue
    Zhang, Mengmeng
    Zhang, Tingting
    Deng, Juan
    Xia, Xiaomeng
    Fang, Xiaoling
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (03) : 707 - 714
  • [8] Calreticulin regulates TGF-β1-induced epithelial mesenchymal transition through modulating Smad signaling and calcium signaling
    Wu, Yanjiao
    Xu, Xiaoli
    Ma, Lunkun
    Yi, Qian
    Sun, Weichao
    Tang, Liling
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2017, 90 : 103 - 113
  • [9] Anthocyanidins inhibit epithelial-mesenchymal transition through a TGF-β/Smad2 signaling pathway in glioblastoma cells
    Ouanouki, Amira
    Lamy, Sylvie
    Annabi, Borhane
    MOLECULAR CARCINOGENESIS, 2017, 56 (03) : 1088 - 1099
  • [10] S100A11 promotes TGF-β1-induced epithelial-mesenchymal transition through SMAD2/3 signaling pathway in intrahepatic cholangiocarcinoma
    Zhang, Meixia
    Zheng, Susu
    Jing, Chuyu
    Zhang, Juan
    Shen, Hujia
    Xu, Xin
    Lin, Jiajia
    Zhang, Boheng
    FUTURE ONCOLOGY, 2018, 14 (09) : 837 - 847